Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA) [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of tirabrutinib (GS-4059) in healthy volunteers and rheumatoid arthritis patients compl…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis [Phase 4]
Phase 4 trial assessing changes in the immune profile in adults with early rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial investigating L-Arginine supplementation as a treatment for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. [Phase 2]
Phase 2 trial assessing efficacy and safety of TAS5315 versus placebo in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis [Phase 1, Phase 2]
Phase 1/2 clinical trial update for E6011 in Japanese subjects with rheumatoid arthritis (completed; results posted).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients [Phase 4]
Phase 4 trial update evaluating the effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis pat…
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics [Phase 3]
Phase 3 clinical trial update evaluating structural efficacy of sarilumab with methotrexate in biologic-naive rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis [Phase 4]
Phase 4 trial evaluating the impact of sarilumab on patient-reported outcomes in active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) [Phase 3]
Phase 3 trial evaluating upadacitinib (ABT-494) in Chinese and select countries' patients with moderately to severely active rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment [Phase 3]
Phase 3 study evaluating the efficacy and safety of ASP015K in rheumatoid arthritis patients with inadequate response to methotrexate has co…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: VACcination In Methotrexate Treated Rheumatoid Arthritis Patients [Phase 3]
A Phase 3 clinical trial update on vaccination in methotrexate-treated rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 [Phase 2]
Phase 2 trial assessing long-term safety and efficacy of GDC-0853 in adults with moderate to severe rheumatoid arthritis has completed with …
-
CLINICAL_TRIALS research · 2020-08-03Clinical Trial Update: Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate [Phase 4]
Phase 4 clinical trial exploring the relationship between methotrexate erythrocyte polyglutamate levels and clinical response in rheumatoid …
-
FDA approval · 2020-07-28FDA Approved: NAPROXEN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Naproxen from Glenmark Pharmaceuticals to update the labeling for the generic product under the …
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Vitamin D Effect in Rheumatoid Arthritis. [Phase 4]
Phase 4 clinical trial evaluating the effect of Vitamin D in active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial assessing safety, efficacy, and pharmacokinetics of ALD518 in active rheumatoid arthritis patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial compares tofacitinib with methotrexate as the first-line DMARD for rheumatoid arthritis, with status currently unkn…
-
FDA approval · 2020-07-06FDA Approved: HULIO — Original Application (Biocon Biologics Inc)
FDA approved HULIO (adalimumab-fkjp) from Biocon Biologics Inc via an original Biologics License Application, a biosimilar to adalimumab. Th…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis
Clinical trial update reporting efficacy and safety of leflunomide in Egyptian patients with active rheumatoid arthritis; study completed wi…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System
Post-market clinical follow-up study of the Zimmer Stafit Acetabular System has been terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor [Phase 2]
Phase 2 trial update on a single IV infusion of allogeneic MPCs in rheumatoid arthritis patients with incomplete response to TNF inhibitors.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Avenir Müller Hip Stem Post Market Surveillance Study
Post-market surveillance study for the Avenir Müller Hip Stem completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) [Phase 1, Phase 2]
Phase 1/2a clinical trial of 99mTc-rhAnnexin V-128 in rheumatoid arthritis and ankylosing spondylitis; trial terminated with results posted …
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs [Phase 3]
Phase 3 trial comparing upadacitinib to abatacept in rheumatoid arthritis patients on csDMARDs with inadequate response or intolerance to bi…
-
FDA approval · 2020-06-01FDA Approved: MELOXICAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' MELOXICAM as an original-application generic meloxicam; the drug is indicated for relief of pain and inf…